全文获取类型
收费全文 | 1720篇 |
免费 | 89篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 53篇 |
妇产科学 | 14篇 |
基础医学 | 250篇 |
口腔科学 | 18篇 |
临床医学 | 134篇 |
内科学 | 301篇 |
皮肤病学 | 49篇 |
神经病学 | 54篇 |
特种医学 | 227篇 |
外科学 | 213篇 |
综合类 | 36篇 |
预防医学 | 53篇 |
眼科学 | 20篇 |
药学 | 154篇 |
中国医学 | 6篇 |
肿瘤学 | 178篇 |
出版年
2023年 | 9篇 |
2022年 | 12篇 |
2021年 | 18篇 |
2020年 | 8篇 |
2019年 | 26篇 |
2018年 | 25篇 |
2017年 | 17篇 |
2016年 | 41篇 |
2015年 | 64篇 |
2014年 | 39篇 |
2013年 | 43篇 |
2012年 | 59篇 |
2011年 | 64篇 |
2010年 | 58篇 |
2009年 | 52篇 |
2008年 | 60篇 |
2007年 | 65篇 |
2006年 | 80篇 |
2005年 | 72篇 |
2004年 | 41篇 |
2003年 | 53篇 |
2002年 | 42篇 |
2001年 | 49篇 |
2000年 | 57篇 |
1999年 | 53篇 |
1998年 | 37篇 |
1997年 | 54篇 |
1996年 | 45篇 |
1995年 | 34篇 |
1994年 | 31篇 |
1993年 | 31篇 |
1992年 | 53篇 |
1991年 | 39篇 |
1990年 | 37篇 |
1989年 | 50篇 |
1988年 | 46篇 |
1987年 | 32篇 |
1986年 | 34篇 |
1985年 | 27篇 |
1984年 | 23篇 |
1983年 | 25篇 |
1982年 | 11篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 6篇 |
排序方式: 共有1825条查询结果,搜索用时 15 毫秒
11.
Association of Epstein-Barr virus with oral cancers 总被引:2,自引:0,他引:2
12.
13.
14.
15.
目的;探讨手术治疗胸椎结核的更好方法。方法;自1990年以来,对21例胸椎结核导致椎柱不稳的患者,应用病灶清除,哈氏棒内固定,椎间及椎板植骨的手术方法。本组平均33.2岁。胸7椎体6例,胸8椎体8例,胸10椎体7例,椎体压缩〈1/2椎体高度13例,〉1/2椎体高度8例,并不全瘫14例。手术中先行病灶清除,然后哈氏棒内固一,撑开后再次清除病灶,取肋骨和髂骨行椎间及椎板上植骨。术后化疗12~15月。结 相似文献
16.
We investigated the relationship between epidermal growth factor (EGF) dependent cell growth and antiproliferative effects of 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) in hormone responsive breast cancer cell lines in vitro. MCF-7 breast cancer cells and GMC-M, which is a serum-independent, hormone receptor-positive subtype derived from MCF-7, were used in this study. EGF stimulated the growth Of both cell lines, and 1,25(OH)(2)D-3 inhibited the EGF-stimulated cell growth in a dose dependent fashion. But treatment with 1,25(OH)(2)D-3 did not change the EGF receptor (EGFR) level significantly in either cell line. GMC-M had a higher level of EGFR and was more sensitive to EGF than MCF-7. These results suggest that other mechanisms of action, which are different from EGFR modulation, concern with the growth inhibitory effect of 1,25(OH)(2)D-3, and that 1,25(OH)(2)D-3 will be a new effective treatment for breast cancer irrespective of EGFR. 相似文献
17.
Discovery and development of novel anticancer drug capecitabine 总被引:1,自引:0,他引:1
Ishitsuka H Shimma N Horii I 《Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan》1999,119(12):881-897
Capecitabine (N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine) is a novel oral fluoropyrimidine carbamate, which was designed to be sequentially converted to 5-fluorouracil (5-FU) by three enzymes located in the liver and in tumors. N4-alkoxycarbonyl-5'-deoxy-5-fluorocytidine derivatives including capecitabine pass intact through the intestinal tract and are sequentially converted to 5-FU by a cascade of the three enzymes. The first step is the conversion to 5'-deoxy-5-fluorocytidine (5'-DFCR) by carboxylesterase located in the liver, then to 5'-deoxy-5-fluorouridine (5'-DFUR) by cytidine deaminase highly expressed in the liver and various solid tumors, and finally to 5-FU by thymidine phosphorylase (dThdPase) preferentially located in tumor tissues. Among large numbers of the derivatives, capecitabine was selected based on its susceptibility to hepatic carboxylesterase, oral bioavailability in monkeys and efficacy in a human cancer xenograft. Capecitabine given orally yielded substantially higher concentrations of 5-FU within tumors than in plasma or normal tissue (muscle). The tumor 5-FU levels were also much higher than those achieved by intraperitoneal administration of 5-FU at equi-toxic doses. This tumor selective delivery of 5-FU ensured greater efficacy and a more favourable safety profile than with other fluoropyrimidines. In 24 human cancer xenograft models studied, capecitabine was more effective at a wider dose range and had a broader spectrum of antitumor activity than 5-FU, UFT or its intermediate metabolite 5'-DFUR. The susceptibility of the xenografts to capecitabine correlated with tumor dThdPase levels. Moreover, the conversion of 5'-DFUR to 5-FU by dThdPase in tumor was insufficient in a xenograft model refractory to capecitabine. In addition, the efficacy of capecitabine was enhanced by dThdPase up-regulators, such as by taxanes and cyclophosphamide and by X-ray irradiation. The efficacy of capecitabine may, therefore, be optimized by selecting the most appropriate patient population based on dThdPase status and/or by combining it with dThdPase up-regulators. Capecitabine has additional characteristics not found with 5-FU, such as potent antimetastatic and anticachectic actions in mouse tumor models. With these profiles, capecitabine may have substantial potential in cancer treatment. 相似文献
18.
A three-dimensional rigid body spring model (3D-RBSM) was used to analyse force distribution through the wrist joint. In the neutral position, 48% of the force was transmitted through the radioscaphoid fossa, 40% through the radiolunate fossa, and 12% through the triangular fibrocartilage complex. In the functional position, the wrist joint was slightly extended, resulting in significantly increased force through the lunate (53%). The lunate appears to bear more load than has been reported previously. 相似文献
19.
A Takeshita K Shinjo K Naito H Matsui K Shigeno S Nakamura T Horii M Maekawa K Kitamura T Naoe K Ohnishi R Ohno 《Leukemia》2003,17(3):648-650
20.
OBJECTIVES: To investigate maternal knowledge and attitudes about otitis media (OM) risk, to estimate the prevalence of risk factors in the first year of life, and to identify barriers to the reduction of risk factors (eg, formula feeding, day care attendance, and exposure to passive smoke). METHODS: Questionnaires mailed to a systematic sample of 504 Minnesota women >/=18 years old identified through 1994 birth certificates. RESULTS: Eighty percent returned a completed survey. According to maternal report, 29% of infants (age 8 to 13 months) had recurrent OM (>/=3 episodes) and 2% had tympanostomy tubes. Forty-six percent attended day care, 29% had >/=1 smoking parent, and 49% breastfed for =2 months. Women were more knowledgeable about OM signs and symptoms than about risk factors. Mean OM knowledge score (the sum of correct true-false responses) was 7.0 (standard deviation = 1.6). Using multiple linear regression, knowledge score was significantly related to marital status, education, age, area of residence, breastfeeding (months), and number of cigarettes smoked per day by the mother, but not to infant or sibling OM history or day care attendance (R = .23). Infant history of OM (odds ratio, 1.9; 95% confidence interval, 1.1 to 3.2) and white race (odds ratio, 0.3; 95% confidence interval, 0. 1 to 0.8), but not the presence of risk factors, were significantly related to having received clinicians' advice about OM prevention advice. CONCLUSION: OM education and prevention programs should target pregnant women and new mothers with OM risk factors, and those who are young, single, and less educated. 相似文献